SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,264.51 330.92
( 0.43%)

Global Indices

Nasdaq

53,583.69 98.81
(0.18%)

Dow Jones

7,750.97 54.27
(0.71%)

Hang Seng

66,369.62 237.64
(0.36%)

Nikkei 225

10,816.31 23.77
(0.22%)

Forex

USD-INR

95.26 -0.05
(-0.05%)

EUR-INR

111.07 -0.11
(-0.10%)

GBP-INR

129.70 -0.28
(-0.21%)

JPY-INR

0.60 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

530549

INE790G01031

138.7336605

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SHILPAMED

112.37

17604.32

EPS(TTM)

Face Value()

Div & Yield %

8.01

0.07

Back

Maxgrow India consolidated net profit rises 190.19% in the June 2026 quarter

Aug 24,2026

Net profit of Maxgrow India rose 190.19% to Rs 199.39 crore in the quarter ended June 2026 as against Rs 68.71 crore during the previous quarter ended June 2025. Sales rose 108.02% to Rs 7384.89 crore in the quarter ended June 2026 as against Rs 3550.07 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	7384.89	3550.07	108
OPM %	2.70	1.94	-
PBDT	199.48	68.94	189
PBT	199.39	68.71	190
NP	199.39	68.71	190

77,264.51 330.92 ( 0.43%)

53,583.69 98.81 (0.18%)

7,750.97 54.27 (0.71%)

66,369.62 237.64 (0.36%)

10,816.31 23.77 (0.22%)

95.26 -0.05 (-0.05%)

111.07 -0.11 (-0.10%)

129.70 -0.28 (-0.21%)

0.60 0.00 (0.01%)